Press release
Global Gene Therapy for Blood Disorders Market Exclusive Report with Detailed Study Analysis
According to the latest gene therapy industry market research report, the global gene therapy for blood disorders market size was valued at US$ 1.13 Billion in 2021, and it is expected to reach US$ 5.79 Billion in 2030, recording a promising CAGR of 21.6 % during the forecast period of 2022 to 2030.
Get the Sample Report:
https://www.insightaceanalytic.com/request-sample/1156
Human genomes are modified through genetic therapy for the treatment of disease. It has excellent potential for treating rare blood diseases like sickle cell anaemia and haemophilia. CRISPR-Cas9, a gene-editing technique, is being adopted as a weapon against rare diseases by many biopharmaceutical corporations. CRISPR Therapeutics and Vertex Pharmaceuticals are conducting a phase I / II trial of CTX001, a CRISPR / Cas9-based genetic therapy, to treat sickle cell disease. In the coming years, the increasing prevalence of genetic and blood disorders, high demand for personalized medicine, increased healthcare expenditures, and increased R&D activities to develop promising genetic therapies for haematology are anticipated to drive the market. According to a study published in the PLOS Medicine Journal, the global incidence of sickle cell anaemia is expected to increase by approximately 30 per cent by 2050. Consequently, the increase in rare haematology disorders is a significant market driver.
Nevertheless, the high cost of gene therapy treatment and the potential adverse effects of the therapies are anticipated to impede the market penetration of gene therapy treatment over the forecast period.
Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1156
The prominent players in the gene therapy for blood disorders industry include:
BioMarin Pharmaceutical Inc. (U.S.), Medgenics (U.S.), Spark Therapeutics (U.S.), bluebird bio, Inc. (U.S.), Shire (U.S.), CRISPR Therapeutics (U.S.), Freeline Therapeutics (U.K.), OrphageniX (U.S.), Errant Gene Therapeutics (U.S.), Sangamo Therapeutics (U.S.), Sigilon Therapeutics, Inc. (U.S.), uniQure (Netherlands), Angiocrine Bioscience (U.S.), and Sanofi Genzyme (U.S.), and other prominent players.
Gene Therapy for Blood Disorders Market Regional Analysis:
North America is predicted to account for the largest share of the gene therapy for blood disorders market during the forecast years, followed by Europe, owing to the rising prevalence of various blood disorders, well-developed healthcare systems, and increasing R&D investments to develop effective gene therapies to treat rare diseases. According to the Hemophilia Federation of America, Hemophilia affects 1 in 5,000 male births, and around 400 babies are born with hemophilia in the U.S annually. Worldwide 400,000 individuals are living with hemophilia, and approximately 20,000 people are living with it in the United States alone.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1156
The Global Gene Therapy for Blood Disorders Market Segments
The Global Gene Therapy for Blood Disorders Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2021 to 2030 based on Indication
• Sickle Cell Anemia
• β-thalassemia
• Hemophilia B
• Hemophilia A
• Other Indication
The Global Gene Therapy for Blood Disorders Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2021 to 2030 based on Mechanism of Action
• Gene Therapy
• Gene Editing
The Global Gene Therapy for Blood Disorders Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2021 to 2030 based on Region
• Europe
• North America
• Latin America
• Asia Pacific
• Middle East & Africa
North America Gene Therapy for Blood Disorders Market Estimates Revenue (US$ Million) by Country, 2021 to 2030
• U.S.
• Canada
Europe Gene Therapy for Blood Disorders Market Estimates Revenue (US$ Million) by Country, 2021 to 2030
• Germany
• Spain
• France
• Russia
• Italy
• Rest of Europe
Asia Pacific Gene Therapy for Blood Disorders Market Estimates Revenue (US$ Million) by Country, 2021 to 2030
• India
• Japan
• China
• Australia & New Zealand
• South Korea
Latin America Gene Therapy for Blood Disorders Market Estimates Revenue (US$ Million) by Country, 2021 to 2030
• Brazil
• Mexico
• Rest of Latin America
The Middle East & Africa Gene Therapy for Blood Disorders Market Estimates Revenue (US$ Million) by Country, 2021 to 2030
• South Africa
• GCC Countries
• Rest of the Middle East & Africa
Get more information: @
https://www.insightaceanalytic.com/report/global-gene-therapy-for-blood-disorders-market/1156
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Gene Therapy for Blood Disorders Market Exclusive Report with Detailed Study Analysis here
News-ID: 3874271 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Veterinary Infectious Disease Diagnostics Market Growth and Restrain Factors Ana …
"Veterinary Infectious Disease Diagnostics Market" in terms of revenue was estimated to be worth $2.06 billion in 2023 and is poised to reach $3.95 billion by 2031, growing at a CAGR of 8.69% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1488
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the veterinary infectious disease diagnostics market are:
• Rising rates of…
Teledermatology Market Exclusive Report on Current Trends and Future Insights
"Teledermatology Market" in terms of revenue was estimated to be worth $10.85 billion in 2023 and is poised to reach $55.17 billion by 2031, growing at a CAGR of 22.73% from 2024 to 2031 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1475
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Teledermatology market are:
• Rising prevalence of skin disorders
• Integration of AI and Machines…
Sugar Free Food And Beverage Market Study Analysis with Forecast to 2034
InsightAce Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Sugar Free Food and Beverage Market (By Product Type (Beverages, Dairy, Confectionery, Bakery, and Others) and Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, Specialty Stores, Online Stores, and Others))- Market Outlook and Industry Analysis 2034"
The global sugar free food and beverage market is estimated to exhibit a CAGR of 3.5% during the forecast period.
Request For Free…
Smart Pill Technology Market is on an Upward Growth Curve
"Smart Pill Technology Market" in terms of revenue was estimated to be worth $4.22 billion in 2023 and is poised to reach $9.21 billion by 2031, growing at a CAGR of 10.55% from 2024 to 2031 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1485
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the smart pill technology market are:
• Technological Advancements
• increasing colon cancer rates
• Increasing elderly…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
